Lithium Ion

Lithium Ion

SCHEMBL1222384

O=C([O-])c1nnc(-c2ccccc2)o1.[Li+]

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 1/20 0.67
▸ ALDH1A1 P00352 3/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ GAA P10253 1/20 0.59
▸ NPC1 O15118 3/20 0.55
▸ RAB9A P51151 3/20 0.55
▸ PKM P14618 1/20 0.54
▸ KDM4E B2RXH2 2/20 0.54
▸ HPGD P15428 2/20 0.54
▸ HSD17B10 Q99714 2/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ RECQL P46063 1/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ CES1 P23141 3/20 0.52
▸ HDAC6 Q9UBN7 1/20 0.49
▸ HIF1A Q16665 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.47
▸ CA1 P00915 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2329020 0.96 PTPN1 (0.67) PTPN1ALDH1A1SMN1; SMN2GAANPC1
SCHEMBL2330752 0.83 PTPN1 (0.93) PTPN1ALDH1A1SMN1; SMN2GAANPC1
SCHEMBL27790021 0.83 PTPN1 (0.73) PTPN1ALDH1A1SMN1; SMN2GAANPC1
Lithium Ion SCHEMBL17377391 0.83 SMPD1 (0.63) PTPN1ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL1222382 0.81 PTPN1 (0.89) PTPN1ALDH1A1SMN1; SMN2GAANPC1
Hydrochloric Acid SCHEMBL19118776 0.81 PTPN1 (0.89) PTPN1ALDH1A1SMN1; SMN2GAANPC1
SCHEMBL2329015 0.81 PTPN1 (0.89) PTPN1ALDH1A1SMN1; SMN2GAANPC1
Hydrochloric Acid SCHEMBL27933403 0.81 PTPN1 (0.71) PTPN1ALDH1A1SMN1; SMN2GAANPC1
SCHEMBL893125 0.80 PTPN1 (0.69) PTPN1ALDH1A1SMN1; SMN2GAANPC1
SCHEMBL3093950 0.80 PTPN1 (0.69) PTPN1ALDH1A1SMN1; SMN2GAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE BISCHOFF ALEXANDER 2011-02-24 — — US disclosed
US-7842696-B2 Piperazine derivatives as inhibitors of stearoyl-CoA desaturase FOREST LABORATORIES HOLDINGS LIMITED (BM) 2010-11-30 — — US disclosed
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2009-09-03 — — US disclosed
WO-2008157844-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE FOREST LABORATORIES HOLDINGS LIMITED (BM) 2008-12-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046134-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 PTPN1 4580/4885ALDH1A1 969/4885SMN1; SMN2 4076/4885
US-20090221583-A1 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE SCD, SCD5, FADS2 PTPN1 4580/4885ALDH1A1 969/4885SMN1; SMN2 4076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback